Literature DB >> 23354781

Metastatic medullary carcinoma of thyroid presenting as a dural-based mass: case report and review of literature.

Arvind Rishi1, Steven Savona, Karen Black, Michael Schulder, Jian Yi Li.   

Abstract

Dural metastasis from medullary thyroid carcinoma (MTC) is not well established in English literature. We present the case report of MTC with unusual clinical presentation as a dural-based mass in a 39-year-old male with no family history of multiple endocrine neoplasia syndrome. Magnetic resonance imaging showed an extra-axial dural-based mass in right frontal lobe with calvarium and soft tissue extension to the right superior orbit. Histopathology showed MTC with variegated morphology and various patterns. Thyroid mass and widespread metastases from medullary thyroid carcinoma were subsequently identified.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23354781     DOI： 10.1007/s12022-013-9233-3

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN： 1046-3976            Impact factor:   3.943


  27 in total

1.  Choroidal metastasis from sporadic medullary thyroid carcinoma.

Authors:  F Rosário; A Garrão; J Laranjeira; M J Bugalho; E Limbert; L G Sobrinho
Journal:  Thyroid       Date:  2005-12       Impact factor: 6.568

Review 2.  Metastatic tumors to the eyelid: report of 20 cases and review of the literature.

Authors:  Carlos Bianciotto; Hakan Demirci; Carol L Shields; Ralph C Eagle; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2009-08

3.  Clinical images. Thyroid follicular carcinoma presenting as intraorbital, intracranial, and subcutaneous metastasis.

Authors:  Thattungal M Anoop; Puthukuli N Mini; Kalikavil P Divya; Suraj Nikhil; Puthiyavettil K Jabbar
Journal:  Am J Surg       Date:  2010-04-21       Impact factor: 2.565

4.  Giant intracranial medullary thyroid carcinoma metastasis presenting as apoplexy.

Authors:  Matthew Bobinski; Claudia M Greco; Rudolph J Schrot
Journal:  Skull Base       Date:  2009-09

5.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

6.  Orbital metastasis as primary manifestation of thyroid carcinoma.

Authors:  C Daumerie; P De Potter; C Godfraind; J Rahier; F Jamar; J P Squifflet
Journal:  Thyroid       Date:  2000-02       Impact factor: 6.568

7.  Orbital metastasis from medullary thyroid carcinoma.

Authors:  Bryan D Seiff; Stuart R Seiff
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2008 Nov-Dec       Impact factor: 1.746

8.  Melanin-producing medullary thyroid carcinoma with glandular differentiation.

Authors:  N Kimura; K Ishioka; Y Miura; N Sasano; K Takaya; T Mouri; T Kimura; Y Nakazato; R Yamada
Journal:  Acta Cytol       Date:  1989 Jan-Feb       Impact factor: 2.319

9.  Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study.

Authors:  G Mendelsohn; S B Baylin; S H Bigner; S A Wells; J C Eggleston
Journal:  Am J Surg Pathol       Date:  1980-08       Impact factor: 6.394

10.  Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary.

Authors:  Katherine Thornton; Geoffrey Kim; V Ellen Maher; Somesh Chattopadhyay; Shenghui Tang; Young Jin Moon; Pengfei Song; Anshu Marathe; Suchitra Balakrishnan; Hao Zhu; Christine Garnett; Qi Liu; Brian Booth; Brenda Gehrke; Robert Dorsam; Leigh Verbois; Debasis Ghosh; Wendy Wilson; John Duan; Haripada Sarker; Sarah Pope Miksinski; Lisa Skarupa; Amna Ibrahim; Robert Justice; Anthony Murgo; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2012-06-04       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.